UPL Ltd.'s share price hit the day's low of ₹583.65 on the BSE, down 6.9% following the announcement of Q1 FY27 results that disappointed investors. According to Business Standard, the stock was trading at ₹585 as of 1.30 PM, down 6.38% as against a 0.43% decline in BSE barometer Sensex to 78,300 levels. The stock has lost 27% so far in 2026 and is down 17% in a year, reflecting sustained investor concerns about the company's performance trajectory. At the current price, the stock is trading at just under 13x its estimated earnings for 2027-28, with investors remaining focused on management changes, volume recovery, and geopolitical uncertainties.
Despite the stock decline, UPL Limited delivered robust financial results for the first quarter of FY2027. The company reported 10.5% year-on-year topline growth to ₹10,181 crore, though this growth was currency and realisation-led as volumes moderated 3% during the quarter. As reported by Business Standard, profit attributable to owners came in at ₹10 crore in the April-June quarter, a significant improvement from a loss of ₹88 crore in the same period last year. The company's EBITDA grew 23% Y-o-Y to ₹1,610 crore, driven by price increases and a better product mix, with EBITDA margin standing at 15.8%, up 160 bps. The company achieved its seventh consecutive quarter of revenue and EBITDA growth and recorded its strongest first-quarter net income performance in three years. On the profitability front, gross margins improved 285 basis points Y-o-Y to 57.6%, supported by lower-cost inventory and a favourable product mix, though operating margin expanded by only 60 bps Y-o-Y to 14.7% due to higher operating costs from forex-led overhead inflation and continued investments in digital initiatives.
The company's regional performance showed mixed results across key markets despite challenging operating conditions. Revenue from its largest market, Latin America (LatAm), grew 8%, led by herbicide and insecticide sales in Brazil, while Colombia and Argentina remained weak. North America reported 18% sales growth, driven by herbicides, fungicides, post-harvest, and aquatic businesses. India registered 15% Y-o-Y growth, with pricing gains offsetting volume softness caused by monsoon disruptions. The European business grew 4% Y-o-Y, aided by favourable currency movements and disciplined pricing actions. The rest of the world business posted 7% growth, backed by strong performance in Indonesia and South Asia. The seeds business (Advanta) recorded 26% revenue growth, lifted by corn sales in India, Indonesia, and LatAm, with the company reiterating its FY27 revenue growth guidance of 7-11% and operating profit growth guidance of 10-14% despite ongoing weather disruptions and geopolitical uncertainties.
UPL Limited has announced a significant leadership restructuring following the decision of CEO Mike Frank to step down as Chief Executive Officer of UPL Corporation Limited. This change will be effective as of 31 August 2026, as Mr. Frank plans to relocate to the United States. The agribusiness major has confirmed that Group Chairman and CEO, Mr. Jai Shroff, will oversee the Global Crop Protection business as part of this leadership transition. This strategic move aims to sustain the continuity of strategic direction while bolstering decision-making efficiencies and executional strength across the organisation's key global markets.
Analysts remain mixed on UPL's prospects despite the strong financial performance and resilient start to FY27. Motilal Oswal Financial Services (MOFSL) maintained its 'Neutral' rating with a target price of ₹600, citing improving pricing discipline and healthy volume-led growth as key drivers, while reiterating its FY27/FY28 earnings estimates. Systematix Research maintained a 'hold' rating with an updated target price of ₹670, noting that while the company delivered resilient performance, near-term growth remains constrained by weather-related volume pressures, uncertain global demand, and geopolitical risks. Elara Capital upgraded UPL to 'Buy' from 'Accumulate' with a target price of ₹783, noting the company's diversified product pipeline across crop protection, seeds, and chemical & NPP makes it portfolio resilient, reflected in its 16% innovation turnover rate. The company has guided for topline growth of 7-11% and EBITDA growth 10-14% in FY27, which shall be volume-led for the next three quarters, with growth expected to be driven by recovery in crop protection volumes globally, continued momentum in seeds and specialty chemicals, and product launches.
